Cingulate Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
CING, CINGW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1901 W. 47 Th Place, Kansas City, KS

There are no Buy or Sell transactions made by insiders since 9/18/2023

Cingulate Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Werth Family Investment Associates LLC 10%+ Owner $1.87M Aug 11, 2023
Peter J. Werth Director, 10%+ Owner $788K Jun 11, 2024
Fountainhead Shrugged, LLC 10%+ Owner $541K Dec 7, 2021
Craig S. Gilgallon EVP and General Counsel $131K Feb 28, 2023
Gregg Wm Givens Director $117K Jun 15, 2023
Louis G. Van Horn EVP and CFO $105K Feb 28, 2023
Thomas Jeffrey Hargroves Director $31.6K Feb 25, 2022
Jennifer L. Callahan SVP and CFO $30.5K Jun 11, 2024
Jeffrey X. Conroy Director $3.31K Feb 25, 2022
Laurie Myers EVP and COO $0 Aug 15, 2024
Patrick Joseph Gallagher Director Jun 15, 2023
Jeffrey S. Ervin Director Jun 11, 2024
Bryan Jay Lawrence Director Jun 11, 2024
Matthew Brams EVP and Chief Medical Officer Jun 28, 2024
Scott Applebaum Director Jun 15, 2023
Curtis Medeiros Director Jun 15, 2023
Shane J. Schaffer Chief Executive Officer, Director Jun 11, 2024
Raul R. Silva EVP and CSO Jun 28, 2024
John A. Roberts Director Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Cingulate Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.